Cargando…
Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study
BACKGROUND: A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125700/ https://www.ncbi.nlm.nih.gov/pubmed/27893841 http://dx.doi.org/10.1371/journal.pone.0167174 |
_version_ | 1782470006435479552 |
---|---|
author | Rahman, Shams Rollison, Dana E. Pierce Campbell, Christine M. Waterboer, Tim Michel, Angelika Pawlita, Michael Villa, Luisa L. Lazcano Ponce, Eduardo Wang, Wei Borenstein, Amy R. Giuliano, Anna R. |
author_facet | Rahman, Shams Rollison, Dana E. Pierce Campbell, Christine M. Waterboer, Tim Michel, Angelika Pawlita, Michael Villa, Luisa L. Lazcano Ponce, Eduardo Wang, Wei Borenstein, Amy R. Giuliano, Anna R. |
author_sort | Rahman, Shams |
collection | PubMed |
description | BACKGROUND: A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men. OBJECTIVES: To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs. METHODS: A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (β types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), α type 27, γ type 4, μ type 1, and ν type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated. RESULTS: Overall, seropositivity to ≥1 cutaneous HPV type (any-HPV) and ≥1 β types (any-β) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for ɤ-HPV 4, μ-HPV 1, and β-HPV 8. No statistically significant association was observed between any-HPV, any-β, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses. CONCLUSIONS: Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men. |
format | Online Article Text |
id | pubmed-5125700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-51257002016-12-15 Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study Rahman, Shams Rollison, Dana E. Pierce Campbell, Christine M. Waterboer, Tim Michel, Angelika Pawlita, Michael Villa, Luisa L. Lazcano Ponce, Eduardo Wang, Wei Borenstein, Amy R. Giuliano, Anna R. PLoS One Research Article BACKGROUND: A variety of cutaneous human papillomaviruses (HPV) are detectable in genital epithelial lesions in men and non-melanoma skin cancer patients. It remains unclear whether these viruses are associated causally with skin lesions. To date, no study has prospectively examined the association between cutaneous HPV seropositivity and development of external genital lesions (EGLs) in men. OBJECTIVES: To examine the association between seropositivity to cutaneous HPV types and the risk of subsequent development of EGLs. METHODS: A nested case-control study including 163 incident EGL cases and 352 EGL-free controls in the HPV Infection in Men (HIM) Study cohort was conducted. Cases were ascertained at each of up to 10 biannual clinical visits and verified through biopsy and pathological diagnoses. EGLs were categorized as condyloma, suggestive of condyloma, penile intraepithelial neoplasia (PeIN), and other EGLs. Archived serum specimens collected at baseline were tested for antibodies against 14 cutaneous HPV types (β types (5, 8, 12, 14, 17, 22, 23, 24, 38, and 47), α type 27, γ type 4, μ type 1, and ν type 41) using a GST L1-based multiplex serology assay. Socio-demographic and sexual behavior data were collected through a questionnaire. Using logistic regression, adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated. RESULTS: Overall, seropositivity to ≥1 cutaneous HPV type (any-HPV) and ≥1 β types (any-β) was 58.3% and 37.5% among other EGL cases, 71.6% and 46.8% among condyloma, 66.8% and 50.0% among PeIN, and 71.9% and 38.4% among controls, respectively. Type-specific seropositivity was most common for ɤ-HPV 4, μ-HPV 1, and β-HPV 8. No statistically significant association was observed between any-HPV, any-β, and type-specific HPV seropositivity and subsequent development of EGLs across all pathological diagnoses. CONCLUSIONS: Overall, seropositivity to cutaneous HPV was common among men; however, it appears that cutaneous HPV is not associated with the development of genital lesions in men. Public Library of Science 2016-11-28 /pmc/articles/PMC5125700/ /pubmed/27893841 http://dx.doi.org/10.1371/journal.pone.0167174 Text en © 2016 Rahman et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rahman, Shams Rollison, Dana E. Pierce Campbell, Christine M. Waterboer, Tim Michel, Angelika Pawlita, Michael Villa, Luisa L. Lazcano Ponce, Eduardo Wang, Wei Borenstein, Amy R. Giuliano, Anna R. Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study |
title | Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study |
title_full | Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study |
title_fullStr | Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study |
title_full_unstemmed | Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study |
title_short | Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study |
title_sort | seroprevalence of cutaneous human papillomaviruses and the risk of external genital lesions in men: a nested case-control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125700/ https://www.ncbi.nlm.nih.gov/pubmed/27893841 http://dx.doi.org/10.1371/journal.pone.0167174 |
work_keys_str_mv | AT rahmanshams seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT rollisondanae seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT piercecampbellchristinem seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT waterboertim seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT michelangelika seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT pawlitamichael seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT villaluisal seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT lazcanoponceeduardo seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT wangwei seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT borensteinamyr seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy AT giulianoannar seroprevalenceofcutaneoushumanpapillomavirusesandtheriskofexternalgenitallesionsinmenanestedcasecontrolstudy |